Sandeep Sahay, MD, FCCP

Assistant Professor of Clinical Medicine, Academic Institute
Houston Methodist
Weill Cornell Medical College


Description of Research

Pulmonary Hypertension

Pulmonary Arterial Hypertension

Interstitial Lung Diseases

Areas Of Expertise

Pulmonary fibrosis Pulmonary hypertension Pulmonary arterial hypertension
Education & Training

MD
Publications

Pulmonary vasodilator treatment in pulmonary hypertension due to left heart or lung disease: time for a high-definition picture?
Piccari, L, Bernardo, RJ, Rodríguez-Chiaradía, D, Vitulo, P, Wort, SJ & Sahay, S 2021, , Pulmonary Circulation, vol. 11, no. 2. https://doi.org/10.1177/20458940211018074

Pregnancy in PAH: Emotions versus reality
Sahay, S & Farber, HW 2021, , Journal of Heart and Lung Transplantation, vol. 40, no. 5, pp. 394-395. https://doi.org/10.1016/j.healun.2021.01.2138

Assessment of pinch force strength in patients with pulmonary arterial hypertension in the era of AOS® dry powder inhaler based therapies
Sahay, S, Holy, R, Lyons, S, Parsley, E, Maurer, M & Weers, J 2021, , Respiratory Medicine, vol. 177, 106308. https://doi.org/10.1016/j.rmed.2021.106308

Impact of inhaled treprostinil on risk stratification with noninvasive parameters: a post hoc analysis of the TRIUMPH and BEAT studies
Tonelli, AR, Sahay, S, Gordon, KW, Edwards, LD, Allmon, AG, Broderick, M & Nelsen, AC 2021, , Pulmonary Circulation, vol. 10, no. 4.

Risk assessment in patients with pulmonary arterial hypertension in the era of COVID 19 pandemic and the telehealth revolution: State of the art review
Wesley Milks, M, Sahay, S, Benza, RL & Farber, HW 2021, , Journal of Heart and Lung Transplantation, vol. 40, no. 3, pp. 172-182. https://doi.org/10.1016/j.healun.2020.12.005

G6PD deficiency and severity of COVID19 pneumonia and acute respiratory distress syndrome: tip of the iceberg?
Youssef, JG, Zahiruddin, F, Youssef, G, Padmanabhan, S, Ensor, J, Pingali, SR, Zu, Y, Sahay, S & Iyer, SP 2021, , Annals of Hematology, vol. 100, no. 3, pp. 667-673. https://doi.org/10.1007/s00277-021-04395-1

Risk stratification in pulmonary hypertension associated with interstitial lung disease: The holy grail?
Beshay, S & Sahay, S 2021, , Journal of Heart and Lung Transplantation, vol. 40, no. 3, pp. 234-235. https://doi.org/10.1016/j.healun.2020.11.010

Impact of human behavior on inspiratory flow profiles in patients with pulmonary arterial hypertension using AOS™ dry powder inhaler device
Sahay, S, Holy, R, Lyons, S, Parsley, E, Maurer, M & Weers, J 2021, , Pulmonary Circulation, vol. 11, no. 1. https://doi.org/10.1177/2045894020985345

Evaluation, Diagnosis, and Classification of Pulmonary Hypertension
Sarah, B, Ashrith, G & Sandeep, S 2021, , Methodist DeBakey cardiovascular journal, vol. 17, no. 2, pp. 86-91. https://doi.org/10.14797/OCDF4453

Drs. Sandeep Sahay and Ashrith Guha Lead Issue on Pulmonary Hypertension
Sahay, S & Guha, A 2021, , Methodist DeBakey cardiovascular journal, vol. 17, no. 2, pp. 83. https://doi.org/10.14797/MULQ7820

Insights and Advances in the Diagnosis, Treatment, and Management of Pulmonary Hypertension
Guha, A & Sahay, S 2021, , Methodist DeBakey cardiovascular journal, vol. 17, no. 2, pp. 84-85. https://doi.org/10.14797/IAME5992

Causes and Circumstances of Death in Portopulmonary Hypertension
Sahay, S, Al Abdi, S, Melillo, C, Newman, J, Dweik, RA, Heresi, GA & Tonelli, AR 2021, , Transplantation Direct. https://doi.org/10.1097/TXD.0000000000001162

Portopulmonary Hypertension: From Bench to Bedside
Thomas, C, Glinskii, V, de Jesus Perez, V & Sahay, S 2020, , Frontiers in Medicine, vol. 7, 569413. https://doi.org/10.3389/fmed.2020.569413

Risk assessment in patients with functional class II pulmonary arterial hypertension: Comparison of physician gestalt with ESC/ERS and the REVEAL 2.0 risk score
Sahay, S, Tonelli, AR, Selej, M, Watson, Z & Benza, RL 2020, , PLoS ONE, vol. 15, no. 11 November, e0241504. https://doi.org/10.1371/journal.pone.0241504

Emerging mechanisms of pulmonary vasoconstriction in SARS-CoV-2-induced acute respiratory distress syndrome (ARDS) and potential therapeutic targets
Karmouty-Quintana, H, Thandavarayan, RA, Keller, SP, Sahay, S, Pandit, LM & Akkanti, B 2020, , International journal of molecular sciences, vol. 21, no. 21, 8081, pp. 1-21. https://doi.org/10.3390/ijms21218081

ERS international congress, Madrid, 2019: Highlights from the pulmonary vascular diseases assembly
Ramjug, S, Weatherald, J, Sahay, S, Foris, JKV, Chandran, N, Bokan, A, Godinas, L & Delcroix, M 2020, , ERJ Open Research, vol. 6, no. 4, 00304-2020, pp. 1-12. https://doi.org/10.1183/23120541.00304-2020

Evaluation and management of pulmonary arterial hypertension
Beshay, S, Sahay, S & Humbert, M 2020, , Respiratory Medicine, vol. 171, 106099. https://doi.org/10.1016/j.rmed.2020.106099

PECAM-1 is Associated WithOutcomes and Response to Treatment in Pulmonary Arterial Hypertension
Clapham, KR, Rao, Y, Sahay, S, Sauler, M, Lee, PJ, Psotka, MA, Fares, WH & Ahmad, T 2020, , American Journal of Cardiology, vol. 127, pp. 198-199. https://doi.org/10.1016/j.amjcard.2020.04.031

Management of hospitalized patients with pulmonary arterial hypertension and COVID-19 infection
Sahay, S & Farber, HW 2020, , Pulmonary Circulation, vol. 10, no. 3. https://doi.org/10.1177/2045894020933480

Impact of race on survival in pulmonary arterial hypertension: Results from the REVEAL registry
Medrek, S, Sahay, S, Zhao, C, Selej, M & Frost, A 2020, , Journal of Heart and Lung Transplantation, vol. 39, no. 4, pp. 321-330. https://doi.org/10.1016/j.healun.2019.11.024